New biotechnology could make testing potential medicine for pulmonary fibrosis, one of the most common and serious forms of lung disease, quicker and less expensive. The innovation, lung-on-a-chip technology, relies on the same technology used to print electronic chips, photolithography.
New biotechnology could make testing potential medicine for pulmonary fibrosis, one of the most common and serious forms of lung disease, quicker and less expensive. The innovation, lung-on-a-chip technology, relies on the same technology used to print electronic chips, photolithography.
Share this Article
Recommended